Bart L. Haagmans

Erasmus Medical Center - Viroscience Department

Netherlands

SCHOLARLY PAPERS

4

DOWNLOADS

341

TOTAL CITATIONS

4

Scholarly Papers (4)

1.

The Safety, Immunogenicity, and Optimal Dosing of an MVA-Based Vaccine Against MERS Coronavirus in Healthy Adults: A Phase 1b, Randomised, Placebo-Controlled, Double-Blind Clinical Trial

Number of pages: 31 Posted: 24 Apr 2024
Erasmus University Rotterdam (EUR) - Department of Viroscience, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Marburg, Philipps University Marburg - Institute of Virology, University of Marburg, University of Hamburg - University Medical Center Hamburg-Eppendorf, Erasmus Medical Center - Viroscience Department, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, Erasmus University Rotterdam (EUR) - Department of Viroscience, Ludwig Maximilian University of Munich (LMU), University of Marburg, Erasmus Medical Center - Viroscience Department, University Medical Center Hamburg-Eppendorf - First Department of Medicine and Independent
Downloads 126 (487,103)
Citation 1

Abstract:

Loading...

Middle East respiratory syndrome coronavirus, MERS-CoV, MERS, modified vaccinia virus Ankara, modified vaccinia Ankara, MVA, MVA-MERS-S

2.

Extended Shedding and Enhanced Fitness of the SARS-CoV-2 Variant of Concern B.1.1.7 in Human Organoid Systems

Number of pages: 47 Posted: 26 Jul 2021
Erasmus Medical Center - Viroscience Department, Erasmus Medical Center - Viroscience Department, Erasmus Medical Center - Viroscience Department, University of Illinois at Urbana-Champaign - Department of Biochemistry, Single Cell Discoveries, Maastricht University - Maastricht Multimodal Molecular Imaging Institute, Erasmus Medical Center - Viroscience Department, University Medical Center, Utrecht - Hubrecht Institute, Single Cell Discoveries, Erasmus Medical Center - Viroscience Department, University of Illinois at Urbana-Champaign - Department of Biochemistry, Erasmus Medical Center - Viroscience Department, Erasmus Medical Center - Viroscience Department, Erasmus Medical Center - Viroscience Department, Maastricht University - The Maastricht Multimodal Molecular Imaging InstituteMaastricht University - The Maastricht Multimodal Molecular Imaging Institute, Single Cell Discoveries, University Medical Center, Utrecht - Hubrecht Institute, University of Illinois at Urbana-Champaign - Department of Biochemistry and Erasmus Medical Center - Viroscience Department
Downloads 97 (591,009)

Abstract:

Loading...

SARS-CoV-2; COVID-19; B.1.1.7; organoids; viral fitness; virus transmission; virus phenotyping

3.

The BNT162b2 mRNA Vaccine Against SARS-CoV-2 Reprograms Both Adaptive and Innate Immune Responses

Number of pages: 29 Posted: 04 May 2021
Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Erasmus Medical Center - Viroscience Department, Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI), Radboud University Nijmegen - Radboud Institute for Molecular Life Sciences (RIMLS), Erasmus University Rotterdam (EUR) - Department of Viroscience, Radboud University Nijmegen - Radboud University Medical Center, Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI) and Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI)
Downloads 83 (650,917)
Citation 3

Abstract:

Loading...

COVID-19, coronaviruses, mRNA vaccines, trained immunity, innate immune tolerance

4.

Two-Component Spike Nanoparticle Vaccine Protects Macaques from SARS-CoV-2 Infection

Number of pages: 42 Posted: 24 Nov 2020
University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Life and Soft, Institut Cochin, University of Southampton - School of Biological Sciences, University of Southampton - School of Biological Sciences, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, Erasmus Medical Center - Viroscience Department, Erasmus Medical Center - Department of Viroscience, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Washington - Department of Biochemistry, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), AIMM Therapeutics BV, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Erasmus Medical Center - Viroscience Department, University of Amsterdam - Amsterdam Public Health Research Institute, Life and Soft, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Southampton - School of Biological Sciences, University of Washington - Department of Biochemistry, University of Paris-Saclay - Molecular Genetics of RNA Viruses, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT) and University of Amsterdam - Department of Medical Microbiology
Downloads 35 (987,330)

Abstract:

Loading...

SARS-CoV-2 vaccine, Self-assembling protein nanoparticle vaccine, SARS-CoV-2 NHP challenge study